Magnetic Glyconanoparticle Production Service
Overview of Magnetic Glyconanoparticle
Magnetic nanoparticles, controllable by magnetic fields, consist of a core formed by magnetic materials like iron, nickel, and cobalt, encased in a functional chemical coating. To elevate their performance at the molecular and cellular levels, surface modifications are employed to enhance dispersion, surface activity, and biocompatibility. These coatings can comprise various carbohydrates, including mannose, galactose, fucose, sialic acid, lactose, dextran, cyclodextrin, and starch. CD BioGlyco's GlycoNano™ Platform provides customized development and production of magnetic glyconanoparticles that integrate the controllable properties of magnetic materials with the biocompatibility and specificity of carbohydrate molecules. The surface chemistry of these magnetic glyconanoparticles is meticulously modulated to refine their physicochemical characteristics, enabling their deployment in diverse fields.
Precision in Nanotechnology: Your Partner in Magnetic Glyconanoparticle Innovation
Our magnetic glyconanoparticle production service has been at the forefront of innovation, leveraging the extensive research advancements of the past decade to deliver high-quality nanoparticles tailored to your specific needs. We employ a variety of sophisticated synthetic methods to produce magnetic nanoparticles with precisely controlled sizes, morphologies, stabilities, and biocompatibilities.
- Ball milling
- Coprecipitation
- Thermal decomposition
- Hydrothermal
- Microemulsion
- Sol-gel
- Biological techniques
Each method is meticulously chosen to ensure that the resulting magnetic glyconanoparticle meets the exacting standards required for your applications. We often synthesize magnetic glyconanoparticles using a co-precipitation technique involving iron (II) and iron (III) chloride salts in a basic environment. Stabilizers such as lactobionic acid, d-gluconic acid, and Ficoll are used to ensure stability and prevent agglomeration of the nanoparticles.
Preparation of Iron Salts Solution
We dissolve the iron salts in deoxygenated water and purge the solution with dry nitrogen to remove any dissolved oxygen that could interfere with the synthesis process.
Addition of Stabilizers
Add the chosen stabilizer (lactobionic acid, d-gluconic acid, or Ficoll) to the iron salt solution to aid in the stabilization of the nanoparticles during formation.
Filtering and Degassing
Filter the reaction mixture through a 0.45 µm nylon filter to remove impurities and then degas the mixture by purging with dry nitrogen for an additional period to ensure an oxygen-free environment.
Heating and Precipitation
We heat the filtered and degassed mixture in an oil bath at 75°C. After heating for a period, we add ammonium hydroxide to the mixture, causing the co-precipitation of the iron salts, indicated by a change in the solution's color from transparent yellow to opaque black. The mixture is stirred overnight to allow for complete nucleation and growth of the magnetite nanoparticles.
Isolation and Dispersion
We isolate the resulting nanoparticles by centrifuging at high speed, removing the supernatant, and resuspending the pellet in distilled water. We repeat this washing step to ensure purity. We sonicate the resuspended nanoparticles in a water bath to disperse any aggregates and facilitate uniform size distribution.
Characterization
We characterize the synthesized magnetic glyconanoparticles using Dynamic Light Scattering (DLS) to determine size distribution and zeta potential, and transmission electron microscopy (TEM) to visualize their morphology and size.
Through these processes, we offer a comprehensive range of tailored magnetic nanoparticles functionalized with various carbohydrate moieties, catering to diverse biomedical applications.
Fucose-Magnetic Nanoparticle Production Service
Fucose-magnetic nanoparticles, offered through our advanced technologies, are surface-modified with fucose, a sugar common in Lewis blood group antigens involved in various immune responses. These particles are used in immunological studies, targeted drug delivery, and biosensor development.
Sialic Acid-Magnetic Nanoparticle Production Service
Our research team provides nanoparticles with sialic acid coatings, which interact with sialic acid-binding proteins and receptors found on cell surfaces. Applications include cell sorting, targeted drug delivery to cells expressing sialic acid receptors, and serving as ligands in biomedical research.
Lactose-Magnetic Nanoparticle Production Service
CD BioGlyco creates particles coated with lactose, a disaccharide known for its stability and interaction with lactose-binding proteins. This makes them suitable for enzyme immobilization, biosensor development and targeted drug delivery to cells expressing lactose receptors.
Dextran-Magnetic Nanoparticle Production Service
The dextran-magnetic nanoparticle production service offers nanoparticles covered with dextran, a polysaccharide renowned for its biocompatibility. These nanoparticles are used in targeted drug delivery, enzyme immobilization, and as carriers for various therapeutic agents.
Cyclodextrin-Magnetic Nanoparticle Production Service
We produce particles functionalized with cyclodextrin, a cyclic oligosaccharide that forms inclusion complexes, enhancing the stability and solubility of enclosed molecules. Applications include drug delivery systems, and carriers for poorly soluble drugs.
Starch-Magnetic Nanoparticle Production Service
We offer a starch-magnetic nanoparticle production service that provides nanoparticles coated with starch, a polysaccharide known for its biocompatibility and biodegradability. These particles are utilized in tissue engineering, and drug delivery, and serve as scaffolds for cell growth and tissue repair.
Workflow of Magnetic Glyconanoparticle Manufacture

Publication Data
DOI: 10.3389/fmats.2019.00179
Journal: Frontiers in Materials
Published: 2019
IF: 2.6
Result: This passage reviews the significant advancements in the field of magnetic nanoparticles, particularly iron oxide nanoparticles, as versatile "theranostic" agents. It highlights the unprecedented increase in research attention over the past two decades, emphasizing their vital roles in imaging, drug delivery, controlled release, hyperthermia, atherosclerosis diagnosis, and prostate cancer treatment. The review discusses the substantial progress made in controlling the size and shape of these nanoparticles through various synthesis methods, such as precipitation, co-precipitation, thermal decomposition, hydrothermal synthesis, microemulsion synthesis, and plant-mediated synthesis. It also addresses the critical challenge of protecting these nanomaterials against corrosion to ensure their stability and functionality in catalysis, biology, and medicine. Finally, the combined applications of imaging and drug delivery in theranostics are explored, along with considerations of the potential toxicity of iron oxide magnetic nanoparticles.
Applications
- Magnetic glyconanoparticles can be used to isolate and purify biochemical products such as proteins.
- Magnetic glyconanoparticles can be used as contrast agents in magnetic resonance imaging, enhancing the visibility of tissues and organs for diagnostic purposes.
- Magnetic glyconanoparticles can be used to label and track cells in vitro and in vivo, facilitating the study of cell behavior and function.
Advantages
- We employ a variety of advanced synthesis methods to ensure that the resulting magnetic glyconanoparticles meet the exacting standards required for various applications.
- Our production service is at the forefront of innovation, leveraging extensive research advancements over the past decade to deliver high-quality nanoparticles.
- We continuously strive to improve our synthesis techniques and production processes to deliver the best possible products to our clients.
Frequently Asked Questions
- Which magnetic particles do we most frequently combine with carbohydrates?
We most commonly use superparamagnetic magnetite, which has become a particularly popular choice due to its excellent biocompatibility and low toxicity, making it a go-to material. These iron oxide-based magnetic glyconanoparticles have garnered significant attention from the scientific community, driving progress in both understanding and application across various fields. Smaller-sized iron oxide magnetic glyconanoparticles are especially favored for biological and biomedical applications. -
What are the types of structures for magnetic nanoparticles?
- Core-shell structure.
- Matrix dispersed structure.
- Janus structure.
- Shell-core-shell structure
CD BioGlyco stands out for its bespoke magnetic glyconanoparticle production, harnessing advanced platforms to develop a diverse array of Glyconanoparticles. Our rigorous synthetic protocols and exhaustive characterization ensure the delivery of high-quality, functionalized nanoparticles, meeting the intricate demands of various biomedical research and applications. If you are interested in our diverse array of sugar-coated nanoparticles, contact us!
Reference
- Gul, S.; et al. A comprehensive review of magnetic nanomaterials modern day theranostics. Frontiers in Materials. 2019, 6: 179.
- Glyco™ Synthesis Platform
- Custom Glycoprotein Synthesis
- Custom Glycoside Synthesis
- Custom Glycosyl Donor Synthesis
- Custom Thioglycoside Synthesis
- Custom Phosphatidylinositol Synthesis
- Custom Cyclodextrin Synthesis
- Custom Rhamnolipid Synthesis
- Custom Sphingolipid Synthesis
- Custom Building Block Synthesis
- Carbohydrate Manufacturing
- Synthesis Process Development and Optimization
- Custom Carbohydrate Synthesis
- Custom Glycolipid Synthesis
- Custom Glycopeptide Synthesis
- Custom Glycoconjugate Synthesis
- Custom Sugar-Nucleotide Synthesis
- Nucleoside & Nucleotide Synthesis Service
- Custom Oligonucleotide Synthesis Service
- Polynucleotide Synthesis Service
- Nucleoside & Nucleotide Modification Service
- Oligonucleotide Modification Service
- Nucleoside-based Production Service
- Nucleotide-based Production Service
- OPME-based NDP-sugar Synthesis Service
- OPME-based NMP-sugar Synthesis Service
- Glycomics Platform
- Glycoproteomics Platform
- N-Glycoproteomics of PDX Models
- Nanotechnologies for the Detection of Glycopeptides
- Glycoprotein Enrichment
- Glycoprotein Quantification
- Glyco-biomarker Detection Service
- Glyco-biomarker AFP Detection Service
- Glyco-biomarker CA19-9 Detection Service
- Glyco-biomarker CA125 Detection Service
- Glyco-biomarker CA15–3 Detection Service
- Glyco-biomarker CEA Detection Service
- Glyco-biomarker PSA Detection Service
- Glyco-biomarker Immunoglobulin G (IgG) Detection Service
- Glyco-biomarker Haptoglobin (Hp) Detection Service
- Glyco-biomarker α1-Antitrypsin (A1AT) Detection Service
- Glyco-biomarker α1-Acid Glycoprotein (AGP) Detection Service
- Glyco-biomarker Ceruloplasmin (CP) Detection Service
- Glyco-biomarker Fetuin A Detection Service
- Site Occupation
- Glycoprotein Structure Analysis
- Glycosylation Site-specific Antibody-Drug Conjugate (ADC) Development Platform
- Carbohydrate-based Glycomedicine Development Platform
- By Sources of Carbohydrate
- By Types of Carbohydrate
- Monosaccharides-based Glycomedicine Development
- Disaccharides-based Glycomedicine Development
- Trisaccharides-based Glycomedicine Development
- Oligosaccharides-based Glycomedicine Development
- Polysaccharides-based Glycomedicine Development
- Glycosides-based Glycomedicine Development
- Glycopeptide-based Glycomedicine Development
- Glycomimetic-based Glycomedicine Development
- By Applications of-based Glycomedicines
- Carbohydrate-based Anticoagulant Glycomedicine Development
- Carbohydrate-based Cardiovascular Glycomedicine Development
- Carbohydrate-based Antitumor Glycomedicine Development
- Carbohydrate-based Antidiabetic Glycomedicine Development
- Carbohydrate-based Antibacterial Glycomedicine Development
- Carbohydrate-based Antiviral Glycomedicines Development
- Carbohydrate-based Antiparasiti Glycomedicine Development
- By Discovery Strategies
- Glycoengineering-based Glycomedicine Development
- Production of Food Ingredients
- Multi-omics Platform for Cancer Glucose Metabolism (MOPCGM)
- Cancer Cell Glycolytic Analysis
- Cancer Cell TCA Cycle Analysis
- Cancer Cell PPP Analysis
- Gene-level Regulation Analysis of Cancer Glucose Metabolism
- Interplay Between Glucose Metabolism Reprogramming and Tumorigenesis & Progression
- Interplay Between Glucose Metabolism Reprogramming and Proliferative Signaling
- Interplay Between Glucose Metabolism Reprogramming and Growth Suppressor
- Interplay Between Glucose Metabolism Reprogramming and Cancer Cell Death
- Interplay Between Glucose Metabolism Reprogramming and Replicative Immortality
- Interplay Between Glucose Metabolism Reprogramming and Angiogenesis
- Interplay Between Glucose Metabolism Reprogramming and Invasion & Metastasis
- Interplay Between Glucose Metabolism Reprogramming and Immune Escape
- Interplay Between Glucose Metabolism Reprogramming and Genomic Instability
- Interplay Between Glucose Metabolism Reprogramming and Tumor-associated Inflammation
- Glucose Metabolism-Microenvironment Crosstalk Analysis in Cancer
- Cancer Glucose Metabolism In Vivo Analysis
- Applications of Studing Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism Small Molecule Inhibitor
- Discovery of Cancer Glucose Metabolism Therapeutic Monoclonal Antibodies
- Development of Gene Therapy Targeting Cancer Glucose Metabolism
- Discovery of Cancer Glucose Metabolism CAR-T Therapy Targeting
- Discovery of Cancer Glucose Metabolism Combination Therapy Strategy
- Discovery of Cancer Glucose Metabolism Precision Therapeutic Strategies
- Glycoengineering Platform
- Therapeutic Nucleic Acid Development Platform
- Therapeutic Oligonucleotide Synthesis Service
- siRNA Synthesis
- miRNA Synthesis
- ASO Synthesis
- Aptamer Synthesis
- PMO Synthesis
- sgRNA Synthesis
- Circular RNA Synthesis
- PNA Synthesis
- Lipid-based GalNac-RNA Delivery Service
- CpG Oligonucleotide Synthesis
- Click-based GalNac-RNA Delivery Service
- AntimiR Synthesis
- GalNAc-siRNA Delivery Service
- tRNA Synthesis
- GalNAc-ASO Delivery Service
- saRNA Synthesis
- Reporter Gene mRNA Synthesis
- Gene Editing mRNA Synthesis
- Gene Replacement mRNA Synthesis
- Cre Recombinase mRNA Synthesis
- hEPO mRNA Synthesis
- OVA mRNA Synthesis
- Therapeutic Oligonucleotide Modification Service
- Therapeutic Oligonucleotide Delivery Development Service
- Targeted Ligand and Linker Synthesis
- Monoantennary GalNac-RNA Delivery
- Biantennary GalNac-RNA Delivery
- Triantennary GalNac-RNA Delivery
- Tetra-antennary GalNac-RNA Delivery
- Solution Phase-based GalNac-RNA Delivery
- Solid Phase-based GalNac-RNA Delivery
- mRNA Poly(A) Tail Length Analysis
- GalNAc-siRNA Delivery
- GalNAc-ASO Delivery
- GalNAc-miRNA Delivery
- GalNAc-Aptamer Delivery
- GalNAc-AntimiR Delivery
- GalNAc-mRNA Delivery
- GalNAc-PNA Delivery
- Peptide-Therapeutic Oligonucleotide Delivery
- LNP-Therapeutic Oligonucleotide Delivery
- PEG-Therapeutic Oligonucleotide Delivery
- Biological Evaluation Service for Therapeutic Oligonucleotide
- mRNA-based Vaccine Development Service
- mRNA Sequence Design&Optimization Service
- mRNA Integrity Analysis ServicemRNA Integrity Analysis Service
- mRNA Biodistribution Analysis Service
- DNA Template Preparation Service
- mRNA Purity Analysis Service
- T Cell Cytokine Secretion Analysis Service
- mRNA Modification Service
- mRNA Length Analysis Service
- mRNA Purification Service
- Neutralizing Antibody Assay Service
- mRNA-LNP Formulation and Encapsulation Service
- mRNA Structural Characterization
- mRNA Structural Characterization Service
- mRNA Bioanalysis Service
- mRNA Residual DNA Template Analysis Service
- mRNA Residual Double-Stranded RNA (dsRNA) Analysis Service
- mRNA Size Analysis Service
- mRNA Polydispersity Analysis Service
- mRNA Zeta Potential Analysis Service
- mRNA Lipid Composition Analysis Service
- Oligonucleotide Drug Process and Formulation Development Service
- RNA Drug Process and Formulation Development
- Therapeutic Oligonucleotide Synthesis Service
- Glycobiology Microarray Platform
- Glyco™ Vaccine Development Platform
- Carbohydrate-based Vaccine Development
- Polysaccharide Vaccine Development
- Tumor-Associated Carbohydrate Vaccine Development
- Glycoconjugate Vaccine Development
- Natural Carbohydrate-based Vaccine Development
- Semi-synthetic Carbohydrate-based Vaccine Development
- Fully Synthetic Carbohydrate-based Vaccine Development
- Carbohydrate-based Antibacterial Vaccine Development
- Carbohydrate-based Antifungal Vaccine Development
- Carbohydrate-based Antiparasitic Vaccine Development
- Carbohydrate-based Antiviral Vaccine Development
- Carbohydrate-based Anticancer Vaccine Development
- Carbohydrate-based Antihelmintic Vaccine Development
- Monovalent Carbohydrate-based Vaccine Development
- Polyvalent Carbohydrate-based Vaccine Development
- Carrier Protein Design Service
- Carbohydrate Conjugation Service for Vaccine Development
- Carbohydrate-based Adjuvant Development
- Lipopolysaccharide-based Adjuvant Development
- Bacterial Outer Membrane Vesicles (OMVs)-based Adjuvant Development
- Trehalose Glycolipid-based Adjuvant Development
- Galactosylceramide-based Adjuvant Development
- Peptidoglycan-based Adjuvant Development
- Chitin/Chitosan-based Adjuvant Development
- Inulin-based Adjuvant Development
- Mannans-based Adjuvant Development
- Alginate-based Adjuvant Development
- Saponin-based Adjuvant Development
- α-Glucan-based Adjuvant Development
- Lentinan-based Adjuvant Development
- β-Glucans-based Adjuvant Development
- Deltin-based Adjuvant Development
- Muramyldipeptide-based Adjuvant Development
- Cord Factor-based Adjuvant Development
- Zwitterionic Polysaccharide-based Adjuvant Development
- Novel Plant Polysaccharides-based Adjuvant Development
- Glycoprotein-based Vaccine Development
- Glycopeptide-based Vaccine Development
- Carbohydrate-based Vaccine Development
- Glycogenomics Platform
- Glycogene Editing Service
- Glycogene Delivery Service
- Glycogene Expression Profiling
- Cancer Glycogene Discovery Service
- Glycogene Discovery Service in Cervical Cancer
- Glycogene Discovery Service in Leukemia
- Glycogene Discovery Service in Bladder Cancer
- Glycogene Discovery Service in Colorectal Adenocarcinoma
- Glycogene Discovery Service in Liver Cancer
- Glycogene Discovery Service in Lymphoma
- Glycogene Discovery Service in Breast Cancer
- Glycogene Discovery Service in Prostate Cancer
- Glycogene Discovery Service in Pancreatic Cancer
- Glycogene Discovery Service in Lung Cancer
- Glycogene Discovery Service in Thyroid Cancer
- Glycogene Discovery Service in Ovarian Cancer
- Glycan Display Platform
- Traditional Glycan Display Array
- Natural Oligosaccharide Library Construction Service
- Chemical Synthesis-based Oligosaccharide Library Construction Service
- Enzymatic Synthesis-based Oligosaccharide Library Construction Service
- Modular Synthesis-based Oligosaccharide Library Construction Service
- Oligosaccharide Library Immobilization Service
- Cell-based Glycan Display Array
- Neoglycolipid (NGL) Display Array
- Liquid Glycan Display Array (LiGA)
- Glycophage Display
- N-linked Glycoprotein-based Glycophage Display System Construction Service
- O-linked Glycoprotein-based Glycophage Display System Construction Service
- Glycophage Display-based Glycosylase Genetic Analysis Service
- Glycophag Display-based Glycoarray Service
- Glycophage Display-based Antibody Development Service
- Glycophage Display-based Epitope Mapping Service
- Glycophage Display-based Biomarker Development Service
- De Novo Glycan Display
- Cell-Surface Glycan Editing
- Examining the Effects of Altering Blood Group Antigens on Erythrocyte Cell Surfaces
- Preventing Cellular Rejection During Transplantation
- Modulating Chemical Composition and Physical Parameters of Glycocalyx
- Tailoring Cell Membranes with Biologically Active Glycans
- Targeting Glycosaminoglycan-mediated Growth Factor Signaling to Influence Stem Cell Specification
- Long-term De Novo Glycan Display for Directing Stem Cell Fate
- Traditional Glycan Display Array
- GlycoNano™ Platform
- Glyconanoparticle Development Service
- Techniques for Glyconanoparticle Development
- Carbohydrate-based Nanoparticle Production
- Gold Glyconanoparticle Production
- Silver Glyconanoparticle
- Magnetic Glyconanoparticle
- Quantum Dot (QD) Glyconanoparticle
- Glyconanoparticle Characterization
- PEG Glyconanoparticle
- Carbon-based Glyconanoparticle
- Fluorescent Glyconanoparticle
- Silica Glyconanoparticle
- Liposome Glyconanoparticle
- Glycol Nanohydrogel Development
- Glycol Nanorod
- Glycol Nanotube
- Glycol Nanocrystal/Nanosheet/Nanosphere/Nanofiber
- Glyconanoparticle Preclinical Study
- Glyconanoparticle Formulation
- Glyconanotechnology-based Biosensor Development
- GlycoNano™ Bioink Production for 3D Printing
- Glyconanoparticle Development Service
- Glyco™ Synthesis Platform





